Memantine for autism spectrum disorder

Journal article


Brignell, Amanda, Marraffa, Catherine, Williams, Katrina and May, Tamara. (2022). Memantine for autism spectrum disorder. Cochrane Database of Systematic Reviews. 2022(8), p. Article CD013845. https://doi.org/10.1002/14651858.CD013845.pub2
AuthorsBrignell, Amanda, Marraffa, Catherine, Williams, Katrina and May, Tamara
Abstract

Background
Autism spectrum disorder (ASD; also known as autism) is a developmental disability that begins in childhood and is typically seen in around 1% to 2% of children. It is characterised by social communication difficulties and repetitive and restricted behaviours and routines that can have a negative impact on a child's quality of life, achievement at school, and social interactions with others. It has been hypothesised that memantine, which is traditionally used to treat dementia, may be effective in reducing the core symptoms of autism as well as some co‐occurring symptoms such as hyperactivity and language difficulties. If memantine is being used to treat the core symptoms of autism, it is important to review the evidence of its effectiveness.

Objectives
To assess the effects of memantine on the core symptoms of autism, including, but not limited to, social communication and stereotypical behaviours.

Search methods
We searched CENTRAL, MEDLINE, Embase, nine other databases and three trials registers up to February 2022. We also checked reference lists of key studies and checked with experts in the field for any additional papers. We searched for retractions of the included studies in MEDLINE, Embase, and the Retraction Watch Database. No retractions or corrections were found.

Selection criteria
We included randomised controlled trials (RCTs) of any dose of memantine compared with placebo in autistic people. We also included RCTs in which only one group received memantine, but both groups received the same additional therapy (e.g. a behaviour intervention).

Data collection and analysis
We used standard Cochrane methods. Our primary outcomes were core autism symptoms and adverse effects. Secondary outcomes were language, intelligence, memory, adaptive behaviour, hyperactivity, and irritability. We used GRADE to assess certainty of evidence.

Main results
We included three RCTs (two double‐blind and one single‐blind) with 204 participants that examined the short‐term effect (immediately postintervention) of memantine in autistic people. Two studies took place in the USA and the other in Iran. All three studies focused on children and adolescents, with a mean age of 9.40 (standard deviation (SD) 2.26) years. Most participants were male (range across studies 73% to 87%). The diagnosis of ASD was based on the Diagnostic and Statistical Manual of Mental Disorders (4th edition; 4th edition, text revision; or 5th edition). To confirm the diagnosis, one study used the Autism Diagnostic Observation Schedule (ADOS) and the Autism Diagnostic Interview‐Revised (ADI‐R); one used ADOS, ADI‐R or the Autism Diagnostic Interview Screener; and one used the Gilliam Autism Rating Scale. Dosage of memantine was based on the child's weight and ranged from 3 mg to 15 mg per day.

Comparisons
Two studies examined memantine compared with placebo; in the other study, both groups had a behavioural intervention while only one group was given memantine.

Risk of bias
All studies were rated at high risk of bias overall, as they were at high or unclear risk of bias across all but four domains in one study, and all but two domains in the other two studies. One study was funded by Forest Laboratories, LLC, (Jersey City, New Jersey), Allergan. The study sponsor was involved in the study design, data collection (via contracted clinical investigator sites), analysis and interpretation of data, and the decision to present these results. The other two studies reported no financial support or sponsorship; though in one of the two, the study medication was an in‐kind contribution from Forest Pharmaceuticals.

Primary outcomes
There was no clear evidence of a difference between memantine and placebo with respect to severity of core symptoms of autism, although we are very uncertain about the evidence. The standardised mean difference in autism symptoms score in the intervention group versus the control group was –0.74 standard deviations (95% confidence interval (CI) −2.07 to 0.58; 2 studies, 181 participants; very low‐certainty evidence; medium effect size); lower scores indicate less severe autistic symptoms. Two studies (144 participants) recorded adverse effects that the authors deemed related to the study and found there may be no difference between memantine and placebo (odds ratio (OR) 0.64, 95% CI 0.17 to 2.39; low‐certainty evidence).

Secondary outcomes
There may be no difference between memantine and placebo on language (2 studies, 144 participants; low‐certainty evidence); memory or adaptive behaviour (1 study, 23 participants; both low‐certainty evidence); or hyperactivity or irritability (1 study, 121 participants; both low‐certainty evidence).

Authors' conclusions
It is unclear whether memantine is an effective treatment for autistic children. None of the three included trials reported on the effectiveness of memantine in adults. Further studies using rigorous designs, larger samples, longer follow‐up and clinically meaningful outcome measures that are important to autistic people and their families will strengthen our knowledge of the effects of memantine in autism.

Year2022
JournalCochrane Database of Systematic Reviews
Journal citation2022 (8), p. Article CD013845
PublisherJohn Wiley & Sons Ltd
ISSN1469-493X
Digital Object Identifier (DOI)https://doi.org/10.1002/14651858.CD013845.pub2
PubMed ID36006807
Scopus EID2-s2.0-85137126227
PubMed Central IDPMC9409629
Open accessOpen access
Page range1-70
Publisher's version
License
All rights reserved
File Access Level
Open
Output statusPublished
Publication dates
Online25 Aug 2022
Publication process dates
Deposited18 Oct 2023
Permalink -

https://acuresearchbank.acu.edu.au/item/8zw57/memantine-for-autism-spectrum-disorder

Download files


Publisher's version
Brignell_2022_Memantine_for_autism_spectrum_disorder.pdf
License: All rights reserved
File access level: Open

  • 44
    total views
  • 18
    total downloads
  • 3
    views this month
  • 1
    downloads this month
These values are for the period from 19th October 2020, when this repository was created.

Export as

Related outputs

Is language ability associated with behaviors of concern in autism? A systematic review
Chan, Charissa Ying Zhen, Williams, Katrina, May, Tamara, Wan, Wei Herng and Brignell, Amanda. (2023). Is language ability associated with behaviors of concern in autism? A systematic review. Autism Research. 16(2), pp. 250-270. https://doi.org/10.1002/aur.2855
Integrating interprofessional electronic medical record teaching in preregistration healthcare degrees : A case study
Lokmic-Tomkins, Zerina, Gray, Kathleen, Cheshire, Lisa, Parolini, Arno, Sharp, Megan, Tarrant, Bronwyn, Hill, Nicole, Rose, David, Webster, Marilyn, Virtue, Debra, Brignell, Amanda, Waring, Rebecca, Broussard, Fiona, Tsirgialos, Alex and Meng Cham, Kwang. (2023). Integrating interprofessional electronic medical record teaching in preregistration healthcare degrees : A case study. International Journal of Medical Informatics. 169, p. Article 104910. https://doi.org/10.1016/j.ijmedinf.2022.104910
Overall prognosis of preschool autism spectrum disorder diagnoses
Brignell, Amanda, Harwood, Rachael C., May, Tamara, Woolfenden, Susan, Montgomery, Alicia, Iorio, Alfonso and Williams, Katrina. (2022). Overall prognosis of preschool autism spectrum disorder diagnoses. Cochrane Database of Systematic Reviews. 2022(9), p. Article CD012749. https://doi.org/10.1002/14651858.CD012749.pub2
Delineating the autistic phenotype in children with neurofibromatosis type 1
Chisholm, Anita K., Haebich, Kristina M., Pride, Natalie A., Walsh, Karin S., Lami, Francesca, Ure, Alex, Maloof, Tiba, Brignell, Amanda, Rouel, Melissa, Granader, Yael, Maier, Alice, Barton, Belinda, Darke, Hayley, Dabscheck, Gabriel, Anderson, Vicki A., Williams, Katrina, North, Kathryn N. and Payne, Jonathon M.. (2022). Delineating the autistic phenotype in children with neurofibromatosis type 1. Molecular Autism. 13, p. Article 3. https://doi.org/10.1186/s13229-021-00481-3
Social motivation a relative strength in DYRK1A syndrome on a background of significant speech and language impairments
Morison, Lottie D., Braden, Ruth O., Amor, David J., Brignell, Amanda, van Bon, Bregje W. M. and Morgan, Angela T.. (2022). Social motivation a relative strength in DYRK1A syndrome on a background of significant speech and language impairments. European Journal of Human Genetics. 30(7), pp. 800-811. https://doi.org/10.1038/s41431-022-01079-w
Sex- and age-related differences in autistic behaviours in children with neurofibromatosis type 1
Chisholm, Anita K., Lami, Francesca, Haebich, Kristina M., Ure, Alex, Brignell, Amanda, Maloof, Tiba, Pride, Natalie A., Walsh, Karin S., Maier, Alice, Rouel, Melissa, Granader, Yael, Barton, Belinda, Darke, Hayley, Fuelscher, Ian, Dabscheck, Gabriel, Anderson, Vicki A., Williams, Katrina, North, Kathryn N. and Payne, Jonathan M.. (2022). Sex- and age-related differences in autistic behaviours in children with neurofibromatosis type 1. Journal of Autism and Developmental Disorders. 53, p. 2835–2850. https://doi.org/10.1007/s10803-022-05571-6
Memantine for autism spectrum disorder
Brignell, Amanda, Prakash, Chidambaram, Marraffa, Catherine, Williams, Katrina and May, Tamara. (2021). Memantine for autism spectrum disorder. Cochrane Database of Systematic Reviews. 2021(1), p. Article CD013845. https://doi.org/10.1002/14651858.CD013845
Identifying and supporting autistic preschoolers and their families
Brignell, Amanda, Cox, Georgina, Ure, Alexandra, Bernie, Charmaine and Williams, Katrina. (2021). Identifying and supporting autistic preschoolers and their families. Australian Journal of General Practice. 50(3), pp. 115-119. https://doi.org/10.31128/AJGP-11-20-5744
Interventions for children and adolescence who stutter : A systematic review, meta-analysis, and evidence map
Brignell, Amanda, Krahe, Michelle, Downes, Martin, Kefalianos, Elaina, Reilly, Sheena and Morgan, Angela. (2021). Interventions for children and adolescence who stutter : A systematic review, meta-analysis, and evidence map. Journal of Fluency Disorders. 70, p. Article 105843. https://doi.org/10.1016/j.jfludis.2021.105843
A modeling-guided case study of disordered speech in minimally verbal children with autism spectrum disorder
Chenausky Karen, V., Brignell, Amanda, Morgan Angela, T., Norton Andrea, C., Tager-Flusberg Helen, B., Schlaug, Gottfried and Guenther Frank, H.. (2021). A modeling-guided case study of disordered speech in minimally verbal children with autism spectrum disorder. American Journal of Speech-Language Pathology. 30(3S), pp. 1542-1557. https://doi.org/10.1044/2021_AJSLP-20-00121
A systematic review of interventions for adults who stutter
Brignell, Amanda, Krahe, Michelle, Downes, Martin, Kefalianos, Elaina, Reilly, Sheena and Morgan, Angela T.. (2020). A systematic review of interventions for adults who stutter. Journal of Fluency Disorders. 64, p. 105766. https://doi.org/10.1016/j.jfludis.2020.105766
Speech and language phenotype in Phelan-McDermid (22q13.3) syndrome
Brignell, Amanda, Gu, Conway, Holm, Alison, Carrigg, Bronwyn, Sheppard, Daisy A., Amor, David J. and Morgan, Angela T.. (2020). Speech and language phenotype in Phelan-McDermid (22q13.3) syndrome. European Journal of Human Genetics. 29(4), pp. 564-574. https://doi.org/10.1038/s41431-020-00761-1
Predicting speech-sound disorder outcomes in school-age children with hearing loss : The VicCHILD experience
St John, Miya, Columbus, Georgie, Brignell, Amanda, Carew, Peter, Skeat, Jemma, Reilly, Sheena and Morgan, Angela T.. (2020). Predicting speech-sound disorder outcomes in school-age children with hearing loss : The VicCHILD experience. International Journal of Language and Communication Disorders. 55(4), pp. 537-546. https://doi.org/10.1111/1460-6984.12536
No differences in code-related emergent literacy skills in well-matched 4-year-old children with and without ASD
Westerveld, Marleen F., Paynter, Jessica, Brignell, Amanda and Reilly, Sheena. (2020). No differences in code-related emergent literacy skills in well-matched 4-year-old children with and without ASD. Journal of Autism and Developmental Disorders. 50(8), pp. 3060-3065. https://doi.org/10.1007/s10803-020-04407-5
Factor analysis of signs of childhood apraxia of speech
Chenausky, Karen V., Brignell, Amanda, Morgan, Angela, Gagné, Danielle, Norton, Andrea, Tager-Flusberg, Helen, Schlaug, Gottfried, Shield, Aaron and Green, Jordan R.. (2020). Factor analysis of signs of childhood apraxia of speech. Journal of Communication Disorders. 87, p. 106033. https://doi.org/10.1016/j.jcomdis.2020.106033
Autism spectrum disorder prevalence in children aged 12–13 years from the longitudinal study of Australian children
May, Tamara, Brignell, Amanda and Williams, Katrina. (2020). Autism spectrum disorder prevalence in children aged 12–13 years from the longitudinal study of Australian children. Autism Research. 13(5), pp. 821-827. https://doi.org/10.1002/aur.2286
Preliminary evidence supports a range of speech sound interventions, but higher-quality studies are needed
Sanchez, Katherine, Brignell, Amanda and Morgan, Angela. (2019). Preliminary evidence supports a range of speech sound interventions, but higher-quality studies are needed. Evidence-based Communication Assessment and Intervention. 13(4), pp. 181-186. https://doi.org/10.1080/17489539.2019.1645982
Predictors and growth in receptive vocabulary from 4 to 8 years in children with and without autism spectrum disorder : A population-based study
Brignell, Amanda, May, Tamara, Morgan, Angela T. and Williams, Katrina. (2019). Predictors and growth in receptive vocabulary from 4 to 8 years in children with and without autism spectrum disorder : A population-based study. Autism: the international journal of research and practice. 23(5), pp. 1322-1334. https://doi.org/10.1177/1362361318801617
Inhibition of Upf2-dependent nonsense-mediated decay leads to behavioral and neurophysiological abnormalities by activating the immune response
Johnson, Jennifer L., Stoica, Loredana, Liu, Yuwei, Zhu, Ping Jun, Bhattacharya, Abhisek, Buffington, Shelly A., Huq, Redwan, Eissa, N. Tony, Larsson, Ola, Porse, Bo T., Domingo, Deepti, Nawaz, Urwah, Carroll, Renee, Jolly, Lachlan, Scerri, Tom S., Kim, Hyung-Goo, Brignell, Amanda, Coleman, Matthew J., Braden, Ruth, ... Costa-Mattioli, Mauro. (2019). Inhibition of Upf2-dependent nonsense-mediated decay leads to behavioral and neurophysiological abnormalities by activating the immune response. Neuron. 104(4), pp. 665-679. https://doi.org/10.1016/j.neuron.2019.08.027
A systematic review and meta-analysis of the prognosis of language outcomes for individuals with autism spectrum disorder
Brignell, Amanda, Morgan, Angela T., Woolfenden, Susan, Klopper, Felicity, May, Tamara, Sarkozy, Vanessa and Williams, Katrina. (2018). A systematic review and meta-analysis of the prognosis of language outcomes for individuals with autism spectrum disorder. Autism & Developmental Language Impairments. 3, pp. 1-9. https://doi.org/10.1177/2396941518767610
Trends in the overlap of autism spectrum disorder and attention deficit hyperactivity disorder : Prevalence, clinical management, language and genetics
May, T., Brignell, A., Hawi, Z., Brereton, A., Tonge, B., Bellgrove, M. A. and Rinehart, N. J.. (2018). Trends in the overlap of autism spectrum disorder and attention deficit hyperactivity disorder : Prevalence, clinical management, language and genetics. Current Developmental Disorders Reports (online). 5(1), pp. 49-57. https://doi.org/10.1007/s40474-018-0131-8
Communication interventions for autism spectrum disorder in minimally verbal children
Brignell, A., Chenausky, K. V., Song, H., Zhu, J., Suo, C. and Morgan, A. T.. (2018). Communication interventions for autism spectrum disorder in minimally verbal children. Cochrane Database of Systematic Reviews. 2018(11), p. CD012324. https://doi.org/10.1002/14651858.CD012324.pub2
Patterns and predictors of language development from 4 to 7 years in verbal children with and without autism spectrum disorder
Brignell, Amanda, Williams, Katrina, Jachno, Kim, Prior, Margot, Reilly, Sheena and Morgan, Angela T.. (2018). Patterns and predictors of language development from 4 to 7 years in verbal children with and without autism spectrum disorder. Journal of Autism and Developmental Disorders. 48(10), pp. 3282-3295. https://doi.org/10.1007/s10803-018-3565-2
Characterization of speech and language phenotype in children with NRXN1 deletions
Brignell, Amanda, St John, Miya, Boys, Amber, Bruce, Amanda, Dinale, Carla, Pigdon, Lauren, Hildebrand, Michael S., Amor, David J. and Morgan, Angela T.. (2018). Characterization of speech and language phenotype in children with NRXN1 deletions. American Journal of Medical Genetics Part B : Neuropsychiatric Genetics. 177(8), pp. 700-708.
Parent-reported patterns of loss and gain in communication in 1- to 2-year-old children are not unique to autism spectrum disorder
Amanda Brignell, Katrina Williams, Margot Prior, Susan Donath, Sheena Reilly, Edith Bavin, Patricia Eadie and Angela Morgan. (2017). Parent-reported patterns of loss and gain in communication in 1- to 2-year-old children are not unique to autism spectrum disorder. Autism: the international journal of research and practice. 21(3), pp. 344-356. https://doi.org/10.1177/1362361316644729
Overall prognosis of preschool autism spectrum disorder diagnoses (Protocol)
Amanda Brignell, Natalia Albein-Urios, Susan Woolfenden, Andrew Hayen, Alfonso Iorio and Katrina Williams. (2017). Overall prognosis of preschool autism spectrum disorder diagnoses (Protocol). Cochrane Database of Systematic Reviews. 2017(8), pp. 1-18. https://doi.org/10.1002/14651858.CD012749
Autism spectrum disorder: Updated prevalence and comparison of two birth cohorts in a nationally representative Australian sample
Tamara May, Emma Sciberras, Amanda Brignell and Katrina Williams. (2017). Autism spectrum disorder: Updated prevalence and comparison of two birth cohorts in a nationally representative Australian sample. BMJ Open. 7(5), pp. 1-9. https://doi.org/10.1136/bmjopen-2016-015549
Communication intervention for autism spectrum disorders in minimally verbal children
Brignell, A., Song, H., Zhu, J., Suo, C., Lu, D. and Morgan, A. T.. (2016). Communication intervention for autism spectrum disorders in minimally verbal children. Cochrane Database of Systematic Reviews. 2016(11), p. Article CD012324. https://doi.org/10.1002/14651858.CD012324
Diagnosing autism : Australian paediatric research network surveys
Randall, Melinda, Albein-Urios, Natalia, Brignell, Amanda, Gulenc, Alisha, Hennel, Sabine, Coates, Cathy, Symeonides, Christos, Hiscock, Harriet, Marraffa, Catherine, Silove, Natalie, Bayl, Vivian, Woolfenden, Susan and Williams, Katrina. (2016). Diagnosing autism : Australian paediatric research network surveys. Journal of Paediatrics and Child Health. 52(1), pp. 11-17. https://doi.org/10.1111/jpc.13029
Regression in autism spectrum disorders
Williams, Katrina, Brignell, Amanda, Prior, Margot, Bartak, Lawrence and Roberts, Jacqueline. (2015). Regression in autism spectrum disorders. Journal of Paediatrics and Child Health. 51(1), pp. 61-64. https://doi.org/10.1111/jpc.12805
How relevant is the framework being used with autism spectrum disorders today?
Amanda Brignell, Angela Morgan, Susan Woolfenden and Katrina Williams. (2014). How relevant is the framework being used with autism spectrum disorders today? International Journal of Speech-Language Pathology. 16(1), pp. 43-49. https://doi.org/10.3109/17549507.2013.861870
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
Williams, Katrina, Brignell, Amanda, Randall, Melinda Joy, Silove, Natalie and Hazell, Philip. (2013). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). The Cochrane Database of Systematic Reviews. 8, pp. 1 - 51. https://doi.org/10.1002/14651858.CD004677.pub3